Advanced glycation end products (AGEs) are the non-enzymatic glycation products of the aldehyde group of reducing sugars and the free amino groups of macromolecular substances such as proteins, amino acids, lipids or nucleic acids in the body under the condition of hyperglycemia. This process is also known as the browning reaction. AGE receptors include RAGE, oligosaccharide transferase -48(OST48, also known as AGE-R1), 80K-H (also known as AGE-R2), galectin-3(AGE-R3) and other AGE-binding proteins such as scavenger receptors. RAGE is a member of the immunoglobulin superfamily. It is mainly responsible for signal transduction and ligand-induced up-regulation after ligand binding.
Excessive deposition of advanced glycation end products (AGEs) can damage the structure of the extracellular matrix, alter its biochemical properties and metabolism, and cause covalent cross-linking of proteins.
The binding of AGE to its receptor RAGE products NAPDH and enhances oxidative stress, activates the NF-κB signaling pathway, and further stimulates the production of cytokines and growth factors, thereby causing damage to cells and tissues. Therefore, this signaling pathway plays an important role in the pathogenesis of diabetic complications.
Binding of AGEs to their receptor RAGE activates a range of signaling pathways, including activation of protein kinase C (PKC), tyrosine phosphorylation of JAK-STAT, PI3K-Akt, MAPK and Calcium signaling pathways. By activating MAPK and PI3K-Akt signaling pathways, NAPDH can be further activated to promote the formation of reactive oxygen species, activation of caspase-3 and degradation of nuclear DNA, leading to nerve cell damage and even apoptosis.
Activation of MAPK signaling pathways, PI3K-Akt signaling pathways and NAPDH promotes the formation of reactive oxygen species, and ultimately leads to the activation of caspase-3 and the degradation of nuclear DNA, thereby causing damage and even apoptosis of nerve cells.
Binding of AGEs to RAGE leads to the production of oxygen free radicals (ROS), which lead to increased transcription of NF-κB and transcription factor activator protein-1 (AP-1). NF-κB and AP-1 further regulate the expression of cytokines, growth factors (such as TNF, IGF-1, IFN-γ) and adhesion molecules (such as ICAM-1, VCAM-1), resulting in disorder of cell function.
AGE-RAGE signaling-mediated diabetic complications include diabetic neuropathy, diabetic nephropathy, diabetic vascular complications, and diabetic foot syndrome. In addition, AGEs also play an important role in most age-related diseases such as Alzheimer's, cancer, cardiovascular disease, kidney disease, high blood pressure, stroke, visual impairment and skin diseases.
|PIM1||PIM1 Antibody||PIM1 Protein||PIM1 cDNA||PIM1 ELISA Kit|
|PLCB1||PLCB1 Antibody||PLCB1 Protein||PLCB1 cDNA||PLCB1 ELISA Kit|
|PLCB2||PLCB2 Antibody||PLCB2 Protein||PLCB2 cDNA||PLCB2 ELISA Kit|
|PLCB3||PLCB3 Antibody||PLCB3 Protein||PLCB3 cDNA||PLCB3 ELISA Kit|
|PLCB4||PLCB4 Antibody||PLCB4 Protein||PLCB4 cDNA||PLCB4 ELISA Kit|
|PLCD1||PLCD1 Antibody||PLCD1 Protein||PLCD1 cDNA||PLCD1 ELISA Kit|
|PLCD3||PLCD3 Antibody||PLCD3 Protein||PLCD3 cDNA||PLCD3 ELISA Kit|
|PLCD4||PLCD4 Antibody||PLCD4 Protein||PLCD4 cDNA||PLCD4 ELISA Kit|
|PLCE1||PLCE1 Antibody||PLCE1 Protein||PLCE1 cDNA||PLCE1 ELISA Kit|
|PLCG1||PLCG1 Antibody||PLCG1 Protein||PLCG1 cDNA||PLCG1 ELISA Kit|
|PLCG2||PLCG2 Antibody||PLCG2 Protein||PLCG2 cDNA||PLCG2 ELISA Kit|
|PRKCA||PRKCA Antibody||PRKCA Protein||PRKCA cDNA||PRKCA ELISA Kit|
|PRKCB||PRKCB Antibody||PRKCB Protein||PRKCB cDNA||PRKCB ELISA Kit|
|PRKCD||PRKCD Antibody||PRKCD Protein||PRKCD cDNA||PRKCD ELISA Kit|
|PRKCE||PRKCE Antibody||PRKCE Protein||PRKCE cDNA||PRKCE ELISA Kit|
|PRKCZ||PRKCZ Antibody||PRKCZ Protein||PRKCZ cDNA||PRKCZ ELISA Kit|
|RAC1||RAC1 Antibody||RAC1 Protein||RAC1 cDNA||RAC1 ELISA Kit|
|RELA||RELA Antibody||RELA Protein||RELA cDNA||RELA ELISA Kit|
|SELE||SELE Antibody||SELE Protein||SELE cDNA||SELE ELISA Kit|
|SERPINE1||SERPINE1 Antibody||SERPINE1 Protein||SERPINE1 cDNA||SERPINE1 ELISA Kit|